Anti-KIR Antibody (Lirilumab)
Catalog No.
F1511
Anti-KIR Antibody (Lirilumab)
Featured Products
Lirilumab (IPH2102) is aanti-KIR A monoclonal antibody with anti-tumor activity. Lirilumab is used in the study of leukemia and squamous cell carcinoma of the head and neck (SCCHN).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.52 kDa
Dry ice
1000676-41-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
IPH 2101, IPH2101, 1-7F9
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P55040
Human
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
KIR
Please avoid freeze-thaw cycles.